Sustiva 100mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sustiva 100mg capsules

bristol-myers squibb pharmaceuticals ltd - efavirenz - capsule - 100mg

Sustiva 50mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sustiva 50mg capsules

bristol-myers squibb pharmaceuticals ltd - efavirenz - capsule - 50mg

Sustiva 200mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sustiva 200mg capsules

bristol-myers squibb pharmaceuticals ltd - efavirenz - capsule - 200mg

Sustiva 600mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sustiva 600mg tablets

bristol-myers squibb pharmaceuticals ltd - efavirenz - tablet - 600mg

Quinsair 240mg nebuliser solution ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

quinsair 240mg nebuliser solution ampoules

chiesi ltd - levofloxacin hemihydrate - nebuliser liquid - 100mg/1ml

Oprymea 0.088mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

oprymea 0.088mg tablets

consilient health ltd - pramipexole dihydrochloride monohydrate - tablet - 88microgram

Oprymea 0.18mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

oprymea 0.18mg tablets

consilient health ltd - pramipexole dihydrochloride monohydrate - tablet - 180microgram

Oprymea 0.35mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

oprymea 0.35mg tablets

consilient health ltd - pramipexole dihydrochloride monohydrate - tablet - 350microgram

Oprymea 0.7mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

oprymea 0.7mg tablets

consilient health ltd - pramipexole dihydrochloride monohydrate - tablet - 700microgram

Pramipexole Teva European Union - English - EMA (European Medicines Agency)

pramipexole teva

teva pharma b.v. - pramipexole dihydrochloride monohydrate - parkinson disease - anti-parkinson drugs - pramipexole teva is indicated for treatment of the signs and symptoms of idiopathic parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end-of-dose or 'on-off' fluctuations).pramipexole teva is indicated in adults for symptomatic treatment of moderate to severe idiopathic restless legs syndrome in doses up to 0.54 mg of base (0.75 mg of salt) (see section 4.2).